KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Income from Continuing Operations (2016 - 2025)

Pfizer (PFE) has disclosed Income from Continuing Operations for 17 consecutive years, with 1640000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 499.03% to 1640000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 13541000000.0, a 68.19% increase, with the full-year FY2025 number at 7786000000.0, down 3.29% from a year prior.
  • Income from Continuing Operations was 1640000000.0 for Q4 2025 at Pfizer, down from 9304000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 20812000000.0 in Q4 2021 to a low of 3334000000.0 in Q4 2023.
  • A 5-year average of 4538166666.67 and a median of 3804500000.0 in 2024 define the central range for Income from Continuing Operations.
  • Biggest YoY gain for Income from Continuing Operations was 9264.52% in 2025; the steepest drop was 499.03% in 2025.
  • Pfizer's Income from Continuing Operations stood at 20812000000.0 in 2021, then plummeted by 58.46% to 8645000000.0 in 2022, then tumbled by 138.57% to 3334000000.0 in 2023, then skyrocketed by 112.33% to 411000000.0 in 2024, then crashed by 499.03% to 1640000000.0 in 2025.
  • Per Business Quant, the three most recent readings for PFE's Income from Continuing Operations are 1640000000.0 (Q4 2025), 9304000000.0 (Q3 2025), and 2903000000.0 (Q2 2025).